Background: We developed a brand new totally bioresorbable vascular scaffold coated with biodegradable poly-L-lactic acid movie (Firesorb-C) for coronary artery perforation. Our vitro exams have demonstrated that Firesorb-C was technically possible however its biosafety and efficacy warranted additional validation in vivo.
Goal: The purpose of this examine was to judge the biosafety and efficacy of Firesorb-C in rabbits.
Strategies: Firesorb-C was deployed on the zone from the belly aorta to the proper iliac artery in 5 rabbits. Angiography was carried out for analysis of the fast efficacy and 6-month biosafety and biodegradability of the Firesorb-C. In the meantime, optical coherence tomography (OCT), histological gentle microscopy (HLM) and scan electron microscopy (SEM) have been carried out to judge the biosafety.
Outcomes: All Firesorb-C functions have been efficiently implanted with out procedure-related issues. In all handled rabbits, angiography confirmed that the Firesorb-C had fully sealed the opening of the left iliac artery with out blood circulation in its branches however with full patency of the proper iliac artery instantly post-procedurally, whereas the coated membrane of Firesorb-C had been degraded and blood circulation was restored within the left iliac artery and its branches at 6 months. OCT additionally discovered that the occluded left iliac artery had been reopened and the stented phase was nearly totally endothelialized with out in-stent restenosis at 6 months, in the meantime HLM and SEM confirmed comparable outcomes.
Conclusions: Firesorb-C is related to wonderful efficacy, biosafety and biodegradability in rabbits. It exhibits promise as a substitute for typical coated stents for therapy of coronary artery perforation or to be used in different scientific conditions.

Mechanical Vibration-Extracted Stromal Vascular Fraction Improves Quantity Retention after Autologous Fats Grafting

Background: The stromal vascular fraction can enhance quantity retention after fats grafting, however the optimum stromal vascular fraction extraction methodology stays controversial. This examine investigated the impact of mechanical vibration on stromal vascular fraction exercise and explored the efficacy of vibration as a brand new extraction methodology in comparison with centrifugation, enzyme digestion, and nanoemulsion strategies.
Strategies: Twenty-four rabbits have been divided into three teams, and adipose tissue was harvested from the scapular area of every rabbit. Within the first group, stromal vascular fraction was extracted from adipose tissue by vibration with totally different frequencies and durations. Cell counts and colony formation have been assessed to find out the optimum vibration parameters. Within the second group, stromal vascular fraction was extracted by the 4 strategies, and the cell counts, proliferation, and adipogenic capabilities have been noticed in vitro. Within the third group, adipose tissue combined with stromal vascular fraction extracted by the use of the 4 strategies was grafted into rabbit ears. Quantity retention and histologic modifications have been evaluated over 24 weeks.
Outcomes: Stromal vascular fraction exercise was not influenced by low-frequency (≤45 Hz) and short-duration (≤20 minutes) vibrations. Vibration at 30 Hz for 15 minutes was most effective for stromal vascular fraction extraction. In vitro, stromal vascular fraction extracted by vibration confirmed benefits for cell viability. In vivo, the vibration group confirmed a extra regular tissue morphology and a better retention charge (60.68 ± 7.07 p.c) than the enzyme digestion (31.88 ± 4.99 p.c), centrifugation (43.76 ± 4.32 p.c), and nanoemulsion teams.
 Efficacy and Biosafety of a New Bioresorbable Vascular Scaffold Covered with Biodegradable Film in Rabbits: An In Vivo Study
Efficacy and Biosafety of a New Bioresorbable Vascular Scaffold Covered with Biodegradable Film in Rabbits: An In Vivo Study

Vascular endothelial progress issue promotes atrial arrhythmias by inducing acute intercalated disk reworking

Atrial fibrillation (AF) is the most typical arrhythmia and is related to irritation. AF sufferers have elevated ranges of inflammatory cytokines recognized to advertise vascular leak, comparable to vascular endothelial progress issue A (VEGF). Nonetheless, the contribution of vascular leak and consequent cardiac edema to the genesis of atrial arrhythmias stays unknown. Earlier work means that interstitial edema within the coronary heart can acutely promote ventricular arrhythmias by disrupting ventricular myocyte intercalated disk (ID) nanodomains wealthy in cardiac sodium channels (Na<sub>V</sub>1.5) and slowing cardiac conduction. Apparently, related disruption of ID nanodomains has been recognized in atrial samples from AF sufferers.

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx103967
  • EUR 343.20
  • EUR 159.60
  • EUR 878.40
  • EUR 477.60
  • EUR 309.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx103968
  • EUR 543.60
  • EUR 159.60
  • EUR 1545.60
  • EUR 744.00
  • EUR 410.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx110617
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx110672
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx104822
  • EUR 543.60
  • EUR 159.60
  • EUR 1545.60
  • EUR 744.00
  • EUR 410.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx175061
  • EUR 994.80
  • EUR 526.80
  • 1 mg
  • 200 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx175062
  • EUR 1011.60
  • EUR 526.80
  • 1 mg
  • 200 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx175063
  • EUR 1011.60
  • EUR 526.80
  • 1 mg
  • 200 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx175064
  • EUR 1045.20
  • EUR 543.60
  • 1 mg
  • 200 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx175065
  • EUR 1095.60
  • EUR 560.40
  • 1 mg
  • 200 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx175066
  • EUR 1111.20
  • EUR 560.40
  • 1 mg
  • 200 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx178841
  • EUR 1412.40
  • EUR 693.60
  • 1 mg
  • 200 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx178842
  • EUR 1579.20
  • EUR 760.80
  • 1 mg
  • 200 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx211194
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx211400
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx141184
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx116592
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx326466
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

abx026640-400ul 400 ul
EUR 627.6

Vascular Endothelial Growth Factor A (VEGFA) Antibody

abx026640-80l 80 µl
EUR 343.2

Vascular Endothelial Growth Factor A (VEGF1) Antibody

abx032785-400ul 400 ul
EUR 627.6

Vascular Endothelial Growth Factor A (VEGF1) Antibody

abx032785-80l 80 µl
EUR 343.2

Vascular Endothelial Growth Factor A (VEGFA) Antibody

abx038156-100ug 100 ug
EUR 469.2

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx132098
  • EUR 360.00
  • EUR 861.60
  • EUR 460.80
  • EUR 184.80
  • EUR 292.80
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx132099
  • EUR 393.60
  • EUR 1011.60
  • EUR 526.80
  • EUR 184.80
  • EUR 309.60
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx132100
  • EUR 360.00
  • EUR 861.60
  • EUR 460.80
  • EUR 184.80
  • EUR 292.80
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx132101
  • EUR 360.00
  • EUR 861.60
  • EUR 460.80
  • EUR 184.80
  • EUR 292.80
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx129994
  • EUR 510.00
  • EUR 159.60
  • EUR 1412.40
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx323797
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody

abx433443-200ul 200 ul
EUR 460.8

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx004364
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Vascular Endothelial Growth Factor A (VEGFA) Antibody

20-abx302653
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vegfa Antibody / Vascular endothelial growth factor a

R32753 100ug
EUR 356.15
Description: VEGF, a homodimeric glycoprotein of relative molecular mass 45,000, is the only mitogen that specifically acts on endothelial cells. It may be a major regulator of tumor angiogenesis in vivo. It is, however, structurally related to platelet-derived growth factor. VEGF shares homology with the PDGF A chain and B chain, including conservation of all 8 cysteines found in PDGFA and PDGFB. VEGF gene contains 8 exons. And VEGF induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. This gene can also regulate haematopoietic stem cell survival by an internal autocrine loop mechanism. What’s more, it also stimulates neurogenesis in vitro and in vivo.

VEGFA Antibody / Vascular Endothelial Growth Factor A

RQ5490 100 ul
EUR 356.15
Description: The VEGFA gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. [RefSeq]

VEGFA Antibody / Vascular Endothelial Growth Factor A

V7175-100UG 100 ug
EUR 349.3
Description: Vascular Endothelial Growth Factor is a member of the PDGF/VEGF growth factor family. It is a heparin-binding protein which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. [RefSeq]

VEGFA Antibody / Vascular Endothelial Growth Factor A

V7175-20UG 20 ug
EUR 153.3
Description: Vascular Endothelial Growth Factor is a member of the PDGF/VEGF growth factor family. It is a heparin-binding protein which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. [RefSeq]

VEGFA Antibody / Vascular Endothelial Growth Factor A

V7175SAF-100UG 100 ug
EUR 349.3
Description: Vascular Endothelial Growth Factor is a member of the PDGF/VEGF growth factor family. It is a heparin-binding protein which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. [RefSeq]

VEGFA Antibody / Vascular Endothelial Growth Factor A

V2925-100UG 100 ug
EUR 349.3
Description: This mAb recognizes proteins of 19-22kDa (reducing) and 38kDa-44kDa (non-reducing), identified as various isoforms of Vascular Endothelial Growth Factor or Vascular Permeability Factor (VEGF/VPF). It is highly specific to VEGF, which is a homodimeric, disulfide-linked glycoprotein with a close homology to platelet derived growth factor (PDGF). There are multiple isoforms of VEGF containing 206-, 189-, 165-, and 121-amino acid residues. The smaller two isoforms, VEGF165 and VEGF121, are secreted proteins and act as diffusible agents, whereas the larger two remain cell associated. VEGF/VPF plays an important role in angiogenesis, which promotes tumor progression and metastasis.

VEGFA Antibody / Vascular Endothelial Growth Factor A

V2925-20UG 20 ug
EUR 153.3
Description: This mAb recognizes proteins of 19-22kDa (reducing) and 38kDa-44kDa (non-reducing), identified as various isoforms of Vascular Endothelial Growth Factor or Vascular Permeability Factor (VEGF/VPF). It is highly specific to VEGF, which is a homodimeric, disulfide-linked glycoprotein with a close homology to platelet derived growth factor (PDGF). There are multiple isoforms of VEGF containing 206-, 189-, 165-, and 121-amino acid residues. The smaller two isoforms, VEGF165 and VEGF121, are secreted proteins and act as diffusible agents, whereas the larger two remain cell associated. VEGF/VPF plays an important role in angiogenesis, which promotes tumor progression and metastasis.

VEGFA Antibody / Vascular Endothelial Growth Factor A

V2925SAF-100UG 100 ug
EUR 349.3
Description: This mAb recognizes proteins of 19-22kDa (reducing) and 38kDa-44kDa (non-reducing), identified as various isoforms of Vascular Endothelial Growth Factor or Vascular Permeability Factor (VEGF/VPF). It is highly specific to VEGF, which is a homodimeric, disulfide-linked glycoprotein with a close homology to platelet derived growth factor (PDGF). There are multiple isoforms of VEGF containing 206-, 189-, 165-, and 121-amino acid residues. The smaller two isoforms, VEGF165 and VEGF121, are secreted proteins and act as diffusible agents, whereas the larger two remain cell associated. VEGF/VPF plays an important role in angiogenesis, which promotes tumor progression and metastasis.

VEGFA Antibody / Vascular Endothelial Growth Factor A

V2926-100UG 100 ug
EUR 349.3
Description: This mAb recognizes proteins of 19-22kDa (reducing) and 38kDa-44kDa (non-reducing), identified as various isoforms of Vascular Endothelial Growth Factor or Vascular Permeability Factor (VEGF/VPF). It is highly specific to VEGF, which is a homodimeric, disulfide-linked glycoprotein with a close homology to platelet derived growth factor (PDGF). There are multiple isoforms of VEGF containing 206-, 189-, 165-, and 121-amino acid residues. The smaller two isoforms, VEGF165 and VEGF121, are secreted proteins and act as diffusible agents, whereas the larger two remain cell associated. VEGF/VPF plays an important role in angiogenesis, which promotes tumor progression and metastasis.

VEGFA Antibody / Vascular Endothelial Growth Factor A

V2926-20UG 20 ug
EUR 153.3
Description: This mAb recognizes proteins of 19-22kDa (reducing) and 38kDa-44kDa (non-reducing), identified as various isoforms of Vascular Endothelial Growth Factor or Vascular Permeability Factor (VEGF/VPF). It is highly specific to VEGF, which is a homodimeric, disulfide-linked glycoprotein with a close homology to platelet derived growth factor (PDGF). There are multiple isoforms of VEGF containing 206-, 189-, 165-, and 121-amino acid residues. The smaller two isoforms, VEGF165 and VEGF121, are secreted proteins and act as diffusible agents, whereas the larger two remain cell associated. VEGF/VPF plays an important role in angiogenesis, which promotes tumor progression and metastasis.

VEGFA Antibody / Vascular Endothelial Growth Factor A

V2926SAF-100UG 100 ug
EUR 349.3
Description: This mAb recognizes proteins of 19-22kDa (reducing) and 38kDa-44kDa (non-reducing), identified as various isoforms of Vascular Endothelial Growth Factor or Vascular Permeability Factor (VEGF/VPF). It is highly specific to VEGF, which is a homodimeric, disulfide-linked glycoprotein with a close homology to platelet derived growth factor (PDGF). There are multiple isoforms of VEGF containing 206-, 189-, 165-, and 121-amino acid residues. The smaller two isoforms, VEGF165 and VEGF121, are secreted proteins and act as diffusible agents, whereas the larger two remain cell associated. VEGF/VPF plays an important role in angiogenesis, which promotes tumor progression and metastasis.

Vascular Endothelial Growth Factor A-A (vegfaa) Antibody

20-abx320017
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular endothelial growth factor A Polyclonal Antibody

42500-100ul 100ul
EUR 399.6

Vascular Endothelial Growth Factor A (VEGFA) Antibody (HRP)

20-abx109181
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody (HRP)

20-abx109235
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody (HRP)

20-abx306412
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody (FITC)

20-abx271211
  • EUR 610.80
  • EUR 309.60
  • EUR 1813.20
  • EUR 844.80
  • EUR 477.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody Pair

abx117524-1pair5x96wellplates 1 pair (5x96 well plates)
EUR 1212

Vascular Endothelial Growth Factor A (VEGFA) Antibody Pair

20-abx370175
  • EUR 1846.80
  • EUR 1195.20
  • 10 × 96 tests
  • 5 × 96 tests

Vascular Endothelial Growth Factor A (VEGFA) Antibody Pair

20-abx370216
  • EUR 1713.60
  • EUR 1111.20
  • 10 × 96 tests
  • 5 × 96 tests

Vascular Endothelial Growth Factor A (VEGFA) Antibody (FITC)

20-abx107764
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody (FITC)

20-abx107818
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody (FITC)

20-abx274032
  • EUR 410.40
  • EUR 260.40
  • EUR 1195.20
  • EUR 594.00
  • EUR 360.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody (FITC)

20-abx274162
  • EUR 526.80
  • EUR 292.80
  • EUR 1496.40
  • EUR 727.20
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody (FITC)

20-abx273838
  • EUR 493.20
  • EUR 276.00
  • EUR 1395.60
  • EUR 678.00
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody (FITC)

20-abx306413
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody (Biotin)

20-abx271477
  • EUR 577.20
  • EUR 292.80
  • EUR 1680.00
  • EUR 794.40
  • EUR 427.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody (Biotin)

20-abx271657
  • EUR 393.60
  • EUR 260.40
  • EUR 1078.80
  • EUR 560.40
  • EUR 343.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody (Biotin)

20-abx271823
  • EUR 477.60
  • EUR 276.00
  • EUR 1296.00
  • EUR 644.40
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody (Biotin)

20-abx106351
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody (Biotin)

20-abx106406
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody (Biotin)

20-abx272615
  • EUR 393.60
  • EUR 260.40
  • EUR 1111.20
  • EUR 560.40
  • EUR 343.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody (Biotin)

20-abx273106
  • EUR 493.20
  • EUR 276.00
  • EUR 1395.60
  • EUR 678.00
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody (Biotin)

20-abx274435
  • EUR 376.80
  • EUR 243.60
  • EUR 927.60
  • EUR 493.20
  • EUR 326.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor A (VEGFA) Antibody (Biotin)

20-abx306414
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor D (FIGF) Antibody

abx117059-100ug 100 ug
EUR 560.4

Vascular Endothelial Growth Factor D (FIGF) Antibody

20-abx001107
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Vascular Endothelial Growth Factor 145 (VEGF145) Antibody

20-abx104214
  • EUR 393.60
  • EUR 159.60
  • EUR 1078.80
  • EUR 543.60
  • EUR 326.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor 145 (VEGF145) Antibody

20-abx104215
  • EUR 360.00
  • EUR 844.80
  • EUR 427.20
  • EUR 184.80
  • EUR 292.80
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor 183 (VEGF183) Antibody

20-abx175182
  • EUR 1111.20
  • EUR 560.40
  • 1 mg
  • 200 ug

Vascular Endothelial Growth Factor 121 (VEGF121) Antibody

20-abx178840
  • EUR 460.80
  • EUR 159.60
  • EUR 1262.40
  • EUR 627.60
  • EUR 360.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor 121 (VEGF121) Antibody

20-abx132299
  • EUR 427.20
  • EUR 1111.20
  • EUR 560.40
  • EUR 184.80
  • EUR 326.40
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor 121 (VEGF121) Antibody

20-abx128591
  • EUR 460.80
  • EUR 159.60
  • EUR 1262.40
  • EUR 627.60
  • EUR 360.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor 121 (VEGF121) Antibody

20-abx129570
  • EUR 510.00
  • EUR 159.60
  • EUR 1412.40
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor 145 (VEGF145) Antibody

20-abx129605
  • EUR 560.40
  • EUR 159.60
  • EUR 1612.80
  • EUR 760.80
  • EUR 410.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor B (VEGFB) Antibody

20-abx318771
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor B (VEGFB) Antibody

20-abx103970
  • EUR 477.60
  • EUR 159.60
  • EUR 1328.40
  • EUR 644.40
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor B (VEGFB) Antibody

20-abx103972
  • EUR 376.80
  • EUR 944.40
  • EUR 493.20
  • EUR 184.80
  • EUR 309.60
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor B (VEGFB) Antibody

20-abx103973
  • EUR 510.00
  • EUR 159.60
  • EUR 1412.40
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor C (VEGFC) Antibody

20-abx103974
  • EUR 477.60
  • EUR 159.60
  • EUR 1279.20
  • EUR 627.60
  • EUR 360.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor C (VEGFC) Antibody

20-abx103975
  • EUR 493.20
  • EUR 159.60
  • EUR 1362.00
  • EUR 661.20
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor C (VEGFC) Antibody

20-abx103976
  • EUR 376.80
  • EUR 927.60
  • EUR 493.20
  • EUR 184.80
  • EUR 309.60
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor D (VEGFD) Antibody

20-abx103977
  • EUR 376.80
  • EUR 159.60
  • EUR 1028.40
  • EUR 526.80
  • EUR 326.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor C (VEGFC) Antibody

20-abx104782
  • EUR 510.00
  • EUR 159.60
  • EUR 1412.40
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor C (VEGFC) Antibody

20-abx110342
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor C (VEGFC) Antibody

20-abx110343
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor D (VEGFD) Antibody

20-abx110344
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor B (VEGFB) Antibody

20-abx104879
  • EUR 543.60
  • EUR 159.60
  • EUR 1545.60
  • EUR 744.00
  • EUR 410.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor C (VEGFC) Antibody

20-abx104880
  • EUR 543.60
  • EUR 159.60
  • EUR 1545.60
  • EUR 744.00
  • EUR 410.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor B (VEGFB) Antibody

20-abx104918
  • EUR 526.80
  • EUR 159.60
  • EUR 1479.60
  • EUR 710.40
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor C (VEGFC) Antibody

20-abx104919
  • EUR 376.80
  • EUR 159.60
  • EUR 994.80
  • EUR 526.80
  • EUR 326.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor C (VEGFC) Antibody

20-abx175067
  • EUR 844.80
  • EUR 427.20
  • 1 mg
  • 200 ug

Vascular Endothelial Growth Factor B (VEGFB) Antibody

20-abx178843
  • EUR 1362.00
  • EUR 661.20
  • 1 mg
  • 200 ug

Vascular Endothelial Growth Factor C (VEGFC) Antibody

20-abx178844
  • EUR 1362.00
  • EUR 661.20
  • 1 mg
  • 200 ug

Vascular Endothelial Growth Factor D (VEGFD) Antibody

20-abx178846
  • EUR 493.20
  • EUR 159.60
  • EUR 1362.00
  • EUR 661.20
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor D (VEGFD) Antibody

20-abx178847
  • EUR 1362.00
  • EUR 661.20
  • 1 mg
  • 200 ug

Vascular Endothelial Growth Factor D (VEGFD) Antibody

20-abx178848
  • EUR 1412.40
  • EUR 693.60
  • 1 mg
  • 200 ug

Vascular Endothelial Growth Factor D (VEGFD) Antibody

20-abx178849
  • EUR 543.60
  • EUR 159.60
  • EUR 1545.60
  • EUR 744.00
  • EUR 410.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Vascular Endothelial Growth Factor C (VEGFC) Antibody

20-abx141233
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

Vascular Endothelial Growth Factor C (VEGFC) Antibody

20-abx132286
  • EUR 376.80
  • EUR 910.80
  • EUR 477.60
  • EUR 184.80
  • EUR 292.80
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Vascular Endothelial Growth Factor B (VEGFB) Antibody

abx117220-100ug 100 ug
EUR 560.4

Vascular endothelial growth factor B (VEGFB) Antibody

abx332754-100ul 100 ul
EUR 510

Vascular endothelial growth factor B (VEGFB) Antibody

20-abx327686
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Vascular endothelial growth factor C (VEGFC) Antibody

20-abx327687
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Vascular Endothelial Growth Factor C (VEGF3) Antibody

abx026521-400ul 400 ul
EUR 627.6

Vascular Endothelial Growth Factor C (VEGF3) Antibody

abx026521-80l 80 µl
EUR 343.2

Vascular Endothelial Growth Factor C (VEGFC) Antibody

abx031500-400ul 400 ul
EUR 627.6

Vascular Endothelial Growth Factor C (VEGFC) Antibody

abx031500-80l 80 µl
EUR 343.2

Vascular Endothelial Growth Factor C (VEGFC) Antibody

abx031501-400ul 400 ul
EUR 627.6
Due to this fact, we examined the speculation that VEGF-induced vascular leak can acutely improve atrial arrhythmia susceptibility by disrupting ID nanodomains and slowing atrial conduction. Remedy of murine hearts with VEGF (30-60 min, at clinically related ranges) extended the electrocardiographic P wave and elevated susceptibility to burst pacing-induced atrial arrhythmias. Optical voltage mapping revealed slower atrial conduction following VEGF therapy. Transmission electron microscopy revealed elevated intermembrane spacing at ID websites adjoining to hole junctions (GJs; 64 ± 9 nm versus 17 ± 1 nm in controls, p < 0.05), in addition to websites subsequent to mechanical junctions (MJs; 63 ± Four nm versus 27 ± 2 nm in controls, p < 0.05) in VEGF-treated hearts relative to controls.